Axsome Therapeutics (AXSM) Stock Price, Quote, News & History

Q: What sector and industry does Axsome Therapeutics (AXSM) operate in?

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Axsome Therapeutics (AXSM) Stock Price, Quote, News & History

AXSMNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$187.35

1.470.79%

At close: Feb 3, 4:00 PM EST

$187.35

N/A

After Hours: 4:00 PM EST

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$188.25

Close

$187.35

Volume / Avg.

910.84K / 653.43K

Day Range

$185.73 - $190.76

52 Wk Range

86.99 - 191.50

Market Cap

$9.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

6.68%

Days to Cover

3.84

Recent Axsome Therapeutics Inc News

Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor

FDA Fast-Tracks Axsome's Alzheimer's Agitation Drug, Stock Soars

The FDA accepted Axsome Therapeutics Inc.'s supplemental NDA for AXS-05 for Alzheimer's agitation with a Priority Review date.

Vandana Singh

Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-100.95M

Investing Cash Flow (TTM)

-439.00K

Financing Cash Flow (TTM)

99.32M

Free Cash Flow (TTM)

-101.39M

Capital Expenditure (TTM)

-439.00K

Net Change in Cash (TTM)

-2.07M

Analyst Trends and Forecast

2

Oct 25

7

Nov 25

1

Dec 25

7

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.26B

PE Ratio (TTM)

-

PE Ratio (FWD)

344.83

PEG Ratio (TTM)

-

PS Ratio (TTM)

16.30

PB Ratio (TTM)

127.10

Earnings Yield % (TTM)

-2.51%

Earnings Yield % (FWD)

0.29%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.46

Company Debt

Total Debt

$187.64M

LT Debt

$117.64M

LT Debt Issuance (TTM)

$260.00M

LT Debt Repayment (TTM)

-$263.90M

Total Cash

$325.27M

Debt to Equity

2.96

Issuance of Debt (TTM)

-$3.90M

Repayment of Debt (TTM)

-$263.90M

Key Statistics

Open

$188.25

Close

$187.35

Volume / Avg.

910.84K / 653.43K

Day Range

$185.73 - $190.76

52 Wk Range

86.99 - 191.50

Market Cap

$9.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

6.68%

Days to Cover

3.84

About

Sector

Health Care

Industry

Pharmaceuticals

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Axsome Therapeutics (AXSM) stock?

A

You can purchase shares of Axsome Therapeutics (NASDAQ:AXSM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Axsome Therapeutics (AXSM) competitors?

A

Other companies in Axsome Therapeutics’s space includes: Novo Nordisk AS (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and Haleon PLC (NYSE:HLN).

Q

What is the forecast, or price target, for Axsome Therapeutics (AXSM) stock?

A

Axsome Therapeutics has a consensus price target of $195.33.

Q

What is the current price for Axsome Therapeutics (AXSM)?

A

The stock price for Axsome Therapeutics (NASDAQ: AXSM) is $187.35 last updated February 3, 2026 at 4:00 PM EST.

Q

Does Axsome Therapeutics (AXSM) pay a dividend?

A

There are no upcoming dividends for Axsome Therapeutics.

Q

When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?

A

Axsome Therapeutics does not have any upcoming earnings scheduled.

Q

Is Axsome Therapeutics (AXSM) going to split?

A

There is no upcoming split for Axsome Therapeutics.

Q

What sector and industry does Axsome Therapeutics (AXSM) operate in?

A

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Jazz Pharmaceuticals PLC

NASDAQ:JAZZ

$166.84

%

Indivior Pharmaceuticals Inc

NASDAQ:INDV

$35.17

-0.79%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$188.25

Close

$187.35

Volume / Avg.

910.84K / 653.43K

Day Range

$185.73 - $190.76

52 Wk Range

86.99 - 191.50

Market Cap

$9.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

6.68%

Days to Cover

3.84

Recent Axsome Therapeutics Inc News

Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor

FDA Fast-Tracks Axsome's Alzheimer's Agitation Drug, Stock Soars

The FDA accepted Axsome Therapeutics Inc.'s supplemental NDA for AXS-05 for Alzheimer's agitation with a Priority Review date.

Vandana Singh

Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-100.95M

Investing Cash Flow (TTM)

-439.00K

Financing Cash Flow (TTM)

99.32M

Free Cash Flow (TTM)

-101.39M

Capital Expenditure (TTM)

-439.00K

Net Change in Cash (TTM)

-2.07M

Analyst Trends and Forecast

2

Oct 25

7

Nov 25

1

Dec 25

7

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.26B

PE Ratio (TTM)

-

PE Ratio (FWD)

344.83

PEG Ratio (TTM)

-

PS Ratio (TTM)

16.30

PB Ratio (TTM)

127.10

Earnings Yield % (TTM)

-2.51%

Earnings Yield % (FWD)

0.29%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.46

Company Debt

Total Debt

$187.64M

LT Debt

$117.64M

LT Debt Issuance (TTM)

$260.00M

LT Debt Repayment (TTM)

-$263.90M

Total Cash

$325.27M

Debt to Equity

2.96

Issuance of Debt (TTM)

-$3.90M

Repayment of Debt (TTM)

-$263.90M

Key Statistics

Open

$188.25

Close

$187.35

Volume / Avg.

910.84K / 653.43K

Day Range

$185.73 - $190.76

52 Wk Range

86.99 - 191.50

Market Cap

$9.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

6.68%

Days to Cover

3.84

About

Sector

Health Care

Industry

Pharmaceuticals

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry